Zobrazeno 1 - 10
of 2 535
pro vyhledávání: '"mrna-1273"'
Autor:
Berthaud V; Meharry Medical College-Division of Infectious Diseases, Clinical and Translational Research Center, Nashville, Tennessee, USA., Creech CB; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rostad CA; Department of Medicine, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Carr Q; MedPharmics, LLC-Albuquerque, Albuquerque, New Mexico, USA., de Leon L; Center for Clinical Trials, LLC, Paramount, California, USA., Dietrich M; Department of Pediatric Infectious Disease, Tulane University School of Medicine, New Orleans, Louisiana, USA., Gupta A; Dr. Anil K. Gupta Medicine Professional Corporation, Toronto, Ontario, Canada., Javita D; Prohealth Research Center, Doral, Florida, USA., Nachman S; Renaissance School of Medicine, SUNY Stony Brook, Stony Brook, New York, USA., Pinninti S; Division of Pediatric Infectious Diseases, University of Alabama at Birmingham/Children's of Alabama, Birmingham, Alabama, USA., Rathore M; University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES), Jacksonville, Florida, USA., Rodriguez CA; Division of Pediatric Infectious Diseases, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA., Luzuriaga K; Program in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA., Towner W; Department of Infectious Diseases, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA., Yeakey A; BioPoint Contracting, Wake Forest, North Carolina, USA., Brown M; Moderna, Inc, Cambridge, Massachusetts, USA., Zhao X; Moderna, Inc, Cambridge, Massachusetts, USA., Deng W; Moderna, Inc, Cambridge, Massachusetts, USA., Xu W; Moderna, Inc, Cambridge, Massachusetts, USA., Zhou H; Moderna, Inc, Cambridge, Massachusetts, USA., Girard B; Moderna, Inc, Cambridge, Massachusetts, USA., Kelly R; Moderna, Inc, Cambridge, Massachusetts, USA., Slobod K; Cambridge ID & Immunology Consulting, LLC, Somerville, Massachusetts, USA., Anderson EJ; Department of Medicine, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Das R; Moderna, Inc, Cambridge, Massachusetts, USA., Miller J; Moderna, Inc, Cambridge, Massachusetts, USA., Schnyder Ghamloush S; Moderna, Inc, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Dec 17; Vol. 79 (6), pp. 1524-1532.
Autor:
Lee A; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Davido B; Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP Université Paris Saclay, Garches, France., Beck E; Health Economics and Outcomes Research, Moderna Inc, Cambridge, MA, USA., Demont C; Health Economics and Outcomes Research, Moderna France, Paris, France., Joshi K; Health Economics and Outcomes Research, Moderna Inc, Cambridge, MA, USA., Kohli M; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Maschio M; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Uhart M; Health Economics and Outcomes Research, Moderna France, Paris, France., El Mouaddin N; Health Economics and Outcomes Research, Moderna France, Paris, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2423474. Date of Electronic Publication: 2024 Nov 14.
Autor:
Du PX; Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan., Chang SS; Division of Transplantation, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Ho TS; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.; Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Pediatrics, Tainan Hospital, Ministry of Health and Welfare, Yunlin, Taiwan.; Department of Pediatrics, National Cheng Kung University Hospital Dou-Liou Branch, College of Medicine, National Cheng Kung University, Yunlin, Taiwan., Shih HC; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, USA., Tsai PS; Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan., Syu GD; Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.; International Center for Wound Repair and Regeneration, National Cheng Kung University, Tainan, Taiwan.; Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.
Publikováno v:
Virulence [Virulence] 2024 Dec; Vol. 15 (1), pp. 2351266. Date of Electronic Publication: 2024 May 08.
Autor:
Kirk B; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Bush C; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Toyip A; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Mues KE; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Beck E; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Ekkehard.Beck@modernatx.com., Li L; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., St Laurent S; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Georgieva M; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Marks MA; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Sun T; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Esposito DB; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Martin D; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Van de Velde N; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126113. Date of Electronic Publication: 2024 Jul 18.
Autor:
Huang YC; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Caldarone L; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Sherman C; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Deutsch R; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Ahn J; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, D.C., Bellanti JA; Department of Pediatrics, Georgetown University School of Medicine, Washington, D.C.
Publikováno v:
Allergy and asthma proceedings [Allergy Asthma Proc] 2024 Nov 01; Vol. 45 (6), pp. 438-446.
Autor:
Isa F; Regeneron Pharmaceuticals, Tarrytown, NY, USA. Electronic address: flonza.isa@regeneron.com., Gonzalez Ortiz AM; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Meyer J; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Hamilton JD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Olenchock BA; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Brackin T; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Ganguly S; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Forleo-Neto E; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Faria L; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Heirman I; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Marovich M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Hutter J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Polakowski L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Irvin SC; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Thakur M; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Hooper AT; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Baum A; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Petro CD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Fakih FA; Clinical Site Partners, d/b/a CSP Orlando, Winter Park, FL, USA., McElrath MJ; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA., De Rosa SC; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA., Cohen KW; Fred Hutchinson Cancer Center, Seattle, WA, USA., Williams LD; Duke University School of Medicine, Durham, NC, USA., Hellman CA; Duke University School of Medicine, Durham, NC, USA., Odeh AJ; Duke University School of Medicine, Durham, NC, USA., Patel AH; Duke University School of Medicine, Durham, NC, USA., Tomaras GD; Duke University School of Medicine, Durham, NC, USA., Geba GP; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Kyratsous CA; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Musser B; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Herman GA; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Jan; Vol. 25 (1), pp. 52-67. Date of Electronic Publication: 2024 Sep 02.
Autor:
Scholaert M; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France.; Genoskin SAS, Toulouse, France., Peries M; Genoskin SAS, Toulouse, France., Braun E; Genoskin SAS, Toulouse, France., Martin J; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France., Serhan N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France., Loste A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France., Bruner A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France., Basso L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France., Chaput B; Department of Plastic, Reconstructive and Aesthetic Surgery, Rangueil Hospital, CHU Toulouse, Toulouse, France., Merle E; Genoskin Inc, Salem, Massachusetts, USA., Descargues P; Genoskin Inc, Salem, Massachusetts, USA., Pagès E; Genoskin SAS, Toulouse, France., Gaudenzio N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291-CNRS UMR5051, University Toulouse III, Toulouse, France.; Genoskin SAS, Toulouse, France.
Publikováno v:
Allergy [Allergy] 2024 Dec; Vol. 79 (12), pp. 3341-3359. Date of Electronic Publication: 2024 Aug 19.
Autor:
Roozen GVT; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, the Netherlands. Electronic address: g.v.t.roozen@lumc.nl., Granger A; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands., van Binnendijk RS; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands., den Hartog G; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands; Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands., Roestenberg M; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, the Netherlands., Visser LG; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126093. Date of Electronic Publication: 2024 Jun 29.
Autor:
Morciano C; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Massari M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Cutillo M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Belleudi V; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Mores N; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy., Sapigni E; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Puccini A; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Zanoni G; Immunology Unit, University Hospital, Verona, Italy., Zorzi M; Cancer Registry of Veneto, Azienda Zero, Padua, Italy., Monaco G; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Del Zotto S; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy., Samez S; Regional Pharmacovigilance Centre, Trieste, Italy., Mayer F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Marano G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Menniti Ippolito F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Da Cas R; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Traversa G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Spila Alegiani S; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy. stefania.spila@iss.it.
Publikováno v:
Drug safety [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1157-1169. Date of Electronic Publication: 2024 Jul 27.
Autor:
Figueroa AL; Moderna, Cambridge, Massachusetts, USA., Azzi JR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Eghtesad B; Cleveland Clinic, Cleveland, Ohio, USA., Priddy F; Moderna, Cambridge, Massachusetts, USA., Stolman D; Moderna, Cambridge, Massachusetts, USA., Siangphoe U; Moderna, Cambridge, Massachusetts, USA., Leony Lasso I; Moderna, Cambridge, Massachusetts, USA., de Windt E; Moderna, Cambridge, Massachusetts, USA., Girard B; Moderna, Cambridge, Massachusetts, USA., Zhou H; Moderna, Cambridge, Massachusetts, USA., Miller JM; Moderna, Cambridge, Massachusetts, USA., Das R; Moderna, Cambridge, Massachusetts, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e591-e600.